Issued Patents All Time
Showing 101–125 of 156 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 8652484 | Delivery system for cytotoxic drugs by bispecific antibody pretargeting | William J. McBride, Christopher A. D'Souza, David M. Goldenberg | 2014-02-18 |
| 8613903 | Humanized L243 antibodies | David M. Goldenberg, Hans J. Hansen, Zhengxing Qu | 2013-12-24 |
| 8603479 | Class I anti-CEA antibodies and uses thereof | Hans J. Hansen, David M. Goldenberg | 2013-12-10 |
| 8597659 | Tetrameric cytokines with improved biological activity | David M. Goldenberg, Edmund A. Rossi | 2013-12-03 |
| 8569054 | Mammalian cell lines for increasing longevity and protein yield from a cell culture | David M. Goldenberg, Zhengxing Qu, Edmund A. Rossi, Jeng-Dar Yang, Diane Nordstrom | 2013-10-29 |
| 8562988 | Strategies for improved cancer vaccines | David M. Goldenberg | 2013-10-22 |
| 8551480 | Compositions and methods of use of immunotoxins comprising ranpirnase (Rap) show potent cytotoxic activity | David M. Goldenberg, Edmund A. Rossi | 2013-10-08 |
| 8491896 | Anti-pancreatic cancer antibodies | David M. Goldenberg, Hans J. Hansen, David V. Gold | 2013-07-23 |
| 8491914 | Dock-and-lock (DNL) complexes for delivery of interference RNA | David M. Goldenberg | 2013-07-23 |
| 8481041 | Dock-and-lock (DNL) constructs for human immunodeficiency virus (HIV) therapy | David M. Goldenberg | 2013-07-09 |
| 8475794 | Combination therapy with anti-CD74 antibodies provides enhanced toxicity to malignancies, Autoimmune disease and other diseases | David M. Goldenberg, Edmund A. Rossi | 2013-07-02 |
| 8470994 | Class I anti-CEA antibodies and uses thereof | Hans J. Hansen, David M. Goldenberg | 2013-06-25 |
| 8435540 | Dimeric alpha interferon PEGylated site-specifically shows enhanced and prolonged efficacy in VIVO | David M. Goldenberg, William J. McBride, Edmund A. Rossi | 2013-05-07 |
| 8435539 | Delivery system for cytotoxic drugs by bispecific antibody pretargeting | William J. McBride, Christopher A. D'Souza, David M. Goldenberg | 2013-05-07 |
| 8383081 | Anti-CD74 immunoconjugates and methods of use | Hans J. Hansen, David M. Goldenberg | 2013-02-26 |
| 8372603 | Mammalian cell lines for increasing longevity and protein yield from a cell culture | David M. Goldenberg, Zhengxing Qu, Edmund A. Rossi, Jeng-Dar Yang, Diane Nordstrom | 2013-02-12 |
| 8349332 | Multiple signaling pathways induced by hexavalent, monospecific and bispecific antibodies for enhanced toxicity to B-cell lymphomas and other diseases | David M. Goldenberg, Edmund A. Rossi | 2013-01-08 |
| 8338140 | Polymeric carriers of therapeutic agents and recognition moieties for antibody-based targeting of disease sites | Serengulam V. Govindan, Sung-Ju Moon, David M. Goldenberg | 2012-12-25 |
| 8333971 | Methods and compositions for treatment of human immunodeficiency virus infection with conjugated antibodies or antibody fragments | David M. Goldenberg, Edmund A. Rossi, William J. McBride | 2012-12-18 |
| 8287865 | Class I anti-CEA antibodies and uses thereof | Hans J. Hansen, David M. Goldenberg | 2012-10-16 |
| 8287864 | Structural variants of antibodies for improved therapeutic characteristics | David M. Goldenberg, Hans J. Hansen | 2012-10-16 |
| 8282934 | Modular method to prepare tetrameric cytokines with improved pharmacokinetics by the dock-and-lock (DNL) technology | David M. Goldenberg, Edmund A. Rossi | 2012-10-09 |
| 8277817 | PEGylation by the dock and lock (DNL) technique | David M. Goldenberg, William J. McBride, Edmund A. Rossi | 2012-10-02 |
| 8246960 | Methods and compositions for generating bioactive assemblies of increased complexity and uses | David M. Goldenberg, William J. McBride, Edmund A. Rossi | 2012-08-21 |
| 8211440 | Multivalent immunoglobulin-based bioactive assemblies | David M. Goldenberg, Edmund A. Rossi | 2012-07-03 |